Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants

Bone Marrow Transplantation
F Z Al-FiarH Messner

Abstract

Thyroid function abnormalities in 270 adult patients post-BMT are described. Various conditioning regimens were used and the effects of three TBI and one chemotherapy only based regimens are compared. The overall incidence of elevated TSH is 8.9; 3.8, 7.2 and 16.7% in those patients who received 300, 500 and 1200 cGy respectively and 11.7% in those who received BuCy conditioning. Three cases (1.1%) of clinial hypothyroidism were observed. Compensated hypothyroidism defined as an elevated TSH in the presence of normal T3, T4 levels and transient in some cases, was the most common finding. All but four cases occurred in the first 2 years after BMT. In the remaining four, three occurred in patients with chronic GVHD. The results reported here show a lower prevalence than observed in most other reviews, particularly for children. A trend was observed with increasing radiation doses. The results are not significantly different from those we observed in the BuCy regimen.

Citations

Nov 3, 2004·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·C CurtilletG Michel
Aug 10, 1999·Critical Reviews in Oncology/hematology·A Gratwohl, A Tyndall
Jul 9, 2002·British Journal of Haematology·Bernadette M D Brennan, Stephen M Shalet
Jun 15, 2006·Journal of Pediatric Hematology/oncology·Vincent LeeChi Kong Li
Jul 5, 2007·Journal of Pediatric Hematology/oncology·Shelley Cathcart, Dean Morrell
Jan 10, 2012·Seminars in Hematology·Uma GunasekaranShubhada M Jagasia
Nov 7, 2007·Endocrinology and Metabolism Clinics of North America·Wassim Chemaitilly, Charles A Sklar
Feb 3, 2005·British Journal of Haematology·R E HoughN M Wulffraat
May 21, 2004·Pediatrics International : Official Journal of the Japan Pediatric Society·Masae MatsumotoOsamu Shinohara
Jun 1, 2005·The American Journal of Medicine·Libuse TauchmanovàAnnamaria Colao
Apr 12, 2016·Bone Marrow Transplantation·C A ClarkB N Savani
Jun 3, 2014·TheScientificWorldJournal·Francesco OrioCarmine Selleri
Jul 29, 2017·Clinical Transplantation·Erden AtillaTaner Demirer
Feb 8, 2018·Bone Marrow Transplantation·Nosha FarhadfarShahrukh K Hashmi
Jun 24, 2018·Journal of Pediatric Endocrinology & Metabolism : JPEM·Luminita N CimaSimona Fica
Jan 11, 2005·Bone Marrow Transplantation·W Y AuY L Kwong
Jul 28, 2020·Clinical Transplantation·Pinar Ataca AtillaGunhan Gurman
Jan 1, 2013·Expert Review of Endocrinology & Metabolism·Zeynep Siklar, Merih Berberoglu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.